CEFACLOR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefaclor, and what generic alternatives are available?
Cefaclor is a drug marketed by Ceph Intl, Chartwell Rx, Dava Pharms Inc, Hikma, Ivax Sub Teva Pharms, Ranbaxy, Teva, Yung Shin Pharm, Facta Farma, Watson Labs Inc, and World Gen. and is included in twenty-nine NDAs.
The generic ingredient in CEFACLOR is cefaclor. There are thirteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefaclor profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefaclor
A generic version of CEFACLOR was approved as cefaclor by TEVA on September 4th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFACLOR?
- What are the global sales for CEFACLOR?
- What is Average Wholesale Price for CEFACLOR?
Summary for CEFACLOR
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 29 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 78 |
| Clinical Trials: | 4 |
| Patent Applications: | 5,290 |
| Drug Prices: | Drug price information for CEFACLOR |
| DailyMed Link: | CEFACLOR at DailyMed |
Recent Clinical Trials for CEFACLOR
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Fundacion Clinic per a la Recerca Biomédica | Phase 4 |
| James Graham Brown Cancer Center | Early Phase 1 |
| Julio Ramirez | Early Phase 1 |
Pharmacology for CEFACLOR
| Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for CEFACLOR
Anatomical Therapeutic Chemical (ATC) Classes for CEFACLOR
US Patents and Regulatory Information for CEFACLOR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yung Shin Pharm | CEFACLOR | cefaclor | FOR SUSPENSION;ORAL | 065412-003 | Feb 17, 2012 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ranbaxy | CEFACLOR | cefaclor | FOR SUSPENSION;ORAL | 064165-001 | Oct 2, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| World Gen | CEFACLOR | cefaclor | TABLET, EXTENDED RELEASE;ORAL | 065057-001 | Jan 5, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ivax Sub Teva Pharms | CEFACLOR | cefaclor | FOR SUSPENSION;ORAL | 064086-001 | Apr 28, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ranbaxy | CEFACLOR | cefaclor | FOR SUSPENSION;ORAL | 064164-001 | Oct 2, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
